This website is for UK Healthcare Professionals only


November: Episode 6     Watch time: 20 min

EADV 2020: congress highlights

The sixth episode looks at the latest updates and hot topics relating to SKYRIZI® (risankizumab) and the psoriasis treatment landscape from the EADV 2020 virtual congress.

Podcast Series Host

Dr Laura Savage

Consultant Dermatologist at Leeds Centre for Dermatology, Chapel Allerton Hospital (Leeds Teaching Hospitals NHS Trust) and an Honorary Senior Lecturer at University of Leeds

Podcast Guest Speakers

Dr Richard Woolf

Consultant Dermatologist, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust


Dr Margo Gkini

Consultant Dermatologist



JULY: Episode 1

Clinical trial spotlight - risankizumab and secukinumab head-to-head in plaque psoriasis

AUGUST: Episode 2

Psoriasis in the time of COVID-19: an era of virtual clinics?             

SEPTEMBER: Episode 3

Psoriasis in practice: BAD guideline updates                               

OCTOBER: Episode 4

BAD 2020: virtual congress highlights

NOVEMBER: Episode 5

Are all IL-23s the same?                    

DECEMBER: Episode 6

EADV 2020: congress highlights       


  1. SKYRIZI (risankizumab) Summary of Product Characteristics.

UK-RISN-210518 Date of Preparation: October 2021